SHMCF yields 0.80% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, SHMCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHMCF + JNJ for your $10,000?
Renewi plc provides waste-to-product services. The company operates through Commercial Waste, Mineralz & Water, and Specialities segments. The Commercial Waste segment engages in the collection and treatment of commercial waste in the Netherlands and Belgium; and processing of wood, aggregates, plastics, paper products, and organic waste. The Mineralz & Water segment decontaminates, stabilizes, and re-uses contaminated materials to produce secondary products for the construction industry in the Netherlands and Belgium; processes and cleans bottom ash, fly ash, and other soils; and handles contaminated soils, old road surfaces, industrial waters, sludges, chemical waste, incinerator residues, and packed hazardous waste. The Specialities segment engages in processing of plants that focuses on recycling and diverting specific waste streams, as well as operates waste treatment facilities for the United Kingdom city and county councils; and recycling of waste from electrical and electronic products, and glass. It operates in the United Kingdom, the Netherlands, Belgium, France, Portugal, and Hungary. The company was formerly known as Shanks Group plc and changed its name to Renewi plc in February 2017. Renewi plc was founded in 1880 and is headquartered in Milton Keynes, the United Kingdom.
Full SHMCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.